273 related articles for article (PubMed ID: 25744809)
21. Mutations of domain V in 23S ribosomal RNA of macrolide-resistant Mycoplasma gallisepticum isolates in Egypt.
Ammar AM; Abd El-Aziz NK; Gharib AA; Ahmed HK; Lameay AE
J Infect Dev Ctries; 2016 Aug; 10(8):807-13. PubMed ID: 27580325
[TBL] [Abstract][Full Text] [Related]
22. Postantibiotic effect and postantibiotic sub-minimum inhibitory concentration effect of valnemulin against Staphylococcus aureus isolates from swine and chickens.
Zhao DH; Yu Y; Zhou YF; Shi W; Deng H; Liu YH
Lett Appl Microbiol; 2014 Feb; 58(2):150-5. PubMed ID: 24117872
[TBL] [Abstract][Full Text] [Related]
23. Molecular Identification and Sequencing of Mycoplasma gallisepticum Recovered from Broilers in Egypt.
A M Younis G; H AbdElgawad R; M Elkenany R; F Glal A
Pak J Biol Sci; 2018 Jan; 21(5):253-261. PubMed ID: 30311489
[TBL] [Abstract][Full Text] [Related]
24. Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers.
Lee HK; DeVito V; Vercelli C; Tramuta C; Nebbia P; Re G; Kovalenko K; Giorgi M
Res Vet Sci; 2017 Jun; 112():26-33. PubMed ID: 28113087
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic and Pharmacodynamic integration of tilmicosin against
Zhang N; Zhou M; Yan X; Liu J; Yuan S; Yang H; Ding H; Zhang D; Bai Y
Front Vet Sci; 2022; 9():952599. PubMed ID: 36246335
[No Abstract] [Full Text] [Related]
26. Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys.
Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
Vet Res Commun; 2006 Oct; 30(7):775-89. PubMed ID: 17004040
[TBL] [Abstract][Full Text] [Related]
27. In vitro susceptibilities to fluoroquinolones in current and archived Mycoplasma gallisepticum and Mycoplasma synoviae isolates from meat-type turkeys.
Gerchman I; Lysnyansky I; Perk S; Levisohn S
Vet Microbiol; 2008 Oct; 131(3-4):266-76. PubMed ID: 18534788
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic and pharmacodynamic modeling of sarafloxacin against avian pathogenic Escherichia coli in Muscovy ducks.
Yu Y; Zhou YF; Sun J; Shi W; Liao XP; Liu YH
BMC Vet Res; 2017 Feb; 13(1):47. PubMed ID: 28183350
[TBL] [Abstract][Full Text] [Related]
29. Escherichia coli serotypes isolated from chickens infected with Mycoplasma gallisepticum.
Sato S; Nonomura I; Hashimoto K
Natl Inst Anim Health Q (Tokyo); 1972; 12(2):63-8. PubMed ID: 4559444
[No Abstract] [Full Text] [Related]
30. Effect of Lonicera japonica extract on Mycoplasma gallisepticum in naturally infected broiler flocks.
Müştak HK; Torun E; Özen D; Yücel G; Akan M; Diker KS
Br Poult Sci; 2015; 56(3):299-303. PubMed ID: 25731588
[TBL] [Abstract][Full Text] [Related]
31. The PK/PD Interactions of Doxycycline against Mycoplasma gallisepticum.
Zhang N; Gu X; Ye X; Wu X; Zhang B; Zhang L; Shen X; Jiang H; Ding H
Front Microbiol; 2016; 7():653. PubMed ID: 27199972
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of novel small molecule inhibitors to control Mycoplasma gallisepticum infection in chickens.
Helmy YA; Kathayat D; Ghanem M; Jung K; Closs G; Deblais L; Srivastava V; El-Gazzar M; Rajashekara G
Vet Microbiol; 2020 Aug; 247():108799. PubMed ID: 32768201
[TBL] [Abstract][Full Text] [Related]
33. Testing the efficacy of fermented wheat germ extract against Mycoplasma gallisepticum infection of chickens.
Stipkovits L; Lapis K; Hidvégi M; Kósa E; Glávits R; Resetár A
Poult Sci; 2004 Nov; 83(11):1844-8. PubMed ID: 15554060
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Tylosin and Tilmicosin Against Experimental
Garmyn A; Vereecken M; De Gussem K; Depondt W; Haesebrouck F; Martel A
Avian Dis; 2019 Jun; 63(2):359-365. PubMed ID: 31251538
[TBL] [Abstract][Full Text] [Related]
35. In vitro evaluation of various antimicrobials against field mycoplasma gallisepticum and mycoplasma synoviae isolates in Egypt.
Abd El-Hamid MI; Awad NFS; Hashem YM; Abdel-Rahman MA; Abdelaziz AM; Mohammed IAA; Abo-Shama UH
Poult Sci; 2019 Dec; 98(12):6281-6288. PubMed ID: 31579902
[TBL] [Abstract][Full Text] [Related]
36.
Huang Z; Wu Y; Zhou Z; Xia X; Gu X; Cai Q; Shen X; Yang H; Ding H
Front Pharmacol; 2019; 10():670. PubMed ID: 31293418
[No Abstract] [Full Text] [Related]
37. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic/Pharmacodynamic Profiles of Tiamulin in an Experimental Intratracheal Infection Model of Mycoplasma gallisepticum.
Xiao X; Sun J; Yang T; Fang X; Cheng J; Xiong YQ; Liu YH
Front Vet Sci; 2016; 3():75. PubMed ID: 27656647
[TBL] [Abstract][Full Text] [Related]
39. The minimum inhibitory concentration of tilmicosin and tylosin for mycoplasma gallisepticum and Mycoplasma synoviae and a comparison of their efficacy in the control of Mycoplasma gallisepticum infection in broiler chicks.
Jordan FT; Horrocks BK
Avian Dis; 1996; 40(2):326-34. PubMed ID: 8790882
[TBL] [Abstract][Full Text] [Related]
40. Lactobacillus salivarius ameliorated Mycoplasma gallisepticum-induced inflammatory injury and secondary Escherichia coli infection in chickens: Involvement of intestinal microbiota.
Wang J; Ishfaq M; Li J
Vet Immunol Immunopathol; 2021 Mar; 233():110192. PubMed ID: 33476924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
